Brief: Initiator Pharma Receives Commitment Of Support From Innovation Fund Denmark
Sept 3 (Reuters) - Initiator Pharma A/S INIT.TE :
* INITIATOR PHARMA RECEIVES COMMITMENT OF SUPPORT FOR
IPED2015
FROM INNOVATION FUND DENMARK
* INNOBOOSTER GRANT WILL SUPPORT ONGOING TRIAL WITH UP TO 2
MDKK
* WE REMAIN CONFIDENT THAT IPED2015 WILL BE A BREAKTHROUGH
THERAPY
FOR PDE5I NON-RESPONDERS
Source text for Eikon: ID:nWkr4SvJZR
Further company coverage: INIT.TE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Initiator Pharma A/S
See all newsBrief: Initiator Pharma Q1 2026 Operating Loss DKK 11.4 Mln
Brief: Initiator Pharma To Fully Prioritize Pudafensine
Brief: Initiator Pharma Reports Q4 Net Revenue Of DKK 0.00
Brief: Initiator Pharma Q4 Operating Loss Widens To DKK 7 Mln
Brief: Initiator Pharma Granted European Patent For Pudafensine in FSD